gvtcx

Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

UK Health Security Agency Published 29 Aug 2025 Contracts Finder

key details

Value£1
Statuscomplete
Category (CPV) 33651600
Deadline10 Mar 2025
Contract start1 Oct 2025
Contract end30 Sept 2029
Procedureopen
SME suitableNo
OCIDocds-b5fd17-427ee398-bfdc-4b3a-8b1e-5b03ad89b555

Awards (2)

This procurement was awarded to 2 suppliers. Values shown are per-award; the notice total is £1.

SupplierValueDateStatus
GlaxoSmithKline UK Ltd - Vaccines shared £1 6 Aug 2025 active
Merck Sharpe & Dohme (UK) Limited shared £1 6 Aug 2025 active

description

Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme.

Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months.

The awarding of lots is not appropriate for this procurement.

Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

3 notices published against this procurement.

PublishedTypeRegimeNotice
13 Dec 2024 Planning (planning) · 663d64f7-1d56-4863-a5a6-c381800c9d72-810614
3 Feb 2025 Tender (tender) · eabe2c22-3fb6-43e3-9fe0-07f9ea93e197-822592
29 Aug 2025 Award (award) · 104b2cd5-fb74-454c-b381-334a14f4a40a-861242

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.